세계의 의약품 약물전달 시장 규모 조사 및 예측, 용도별, 투여 경로별 및 지역별 분석(2022-2029년)

Global Pharmaceutical Drug Delivery Market is valued at approximately USD 1377.28 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period 2022-2029. Pharmaceutical drug delivery is a formulation or device used to administer a medicinal material into the body. This technique works by delivering pharmaceuticals to the body's targeted areas with the use of a medium that can control the administration of the therapy using either a chemical or a physiological trigger. The different routes by which pharmaceutical medications are administered are oral, intravenous injection, cutaneous absorption, and inhalation. The global market growth is being driven by the factors such as high incidences of chronic diseases among the population, surging demand for biosimilars and biologics, increasing government support for research in the field of drug delivery, and rising concerns & awareness about health care. The World Health Organization stated that cardiovascular diseases account for the leading cause of death with around 17.9 million cases worldwide. Similarly, according to the International Diabetes Federation, the diabetic population is likely to reach 783 million by the year 2045.

In addition, the growing investments in pharmaceutical R&D are acting as a catalyzing factor for the growth of the market across the globe. The globalization of healthcare has expanded the scope of pharmaceuticals, which represents significant growth opportunities. Pharmaceutical companies are investing in R&D to develop drugs that are tailored to the specific needs of the customers. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 207 billion and it is projected to reach around USD 265 billion by the year 2025. Thereby, the increasing investments in pharmaceutical R&D are attributed to market development. Moreover, the growing trend of self-administration and home care, as well as increasing technological advancements and new product launches are presenting various lucrative opportunities over the forecasting years. However, the increasing number of drug recalls and drug failures is challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the easy availability of pharmaceutical drug delivery systems, rising government support, rising government initiatives, along with modernize healthcare infrastructure. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing incidences of chronic diseases including cancer, respiratory allergies, and diabetes, rising awareness regarding the use of pharmaceutical drug delivery products as well as the growth of the life science industry across the APAC region.

Major market players included in this report are:

• Bayer AG
• Becton, Dickinson and Company
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• Johnson & Johnson Private Limited
• Merck & Co., Inc.
• Novartis AG
• 3M Company
• Pfizer Inc.
• Sanofi S.A.

Recent Developments in the Market:

• In June 2020, GlaxoSmithKline plc partnered with IDEAYA to enter the field of synthetic lethality, which continues to advance in oncology. The clinical trials for its programs MAT2A, Pol Theta, and Werner Helicase are anticipated to begin within the next three years.
• In July 2021, Johnson & Johnson received FDA approval for DARZALEX (daratumumab), a subcutaneous formulation that shortens the duration of treatment for multiple myeloma patients.

Global Pharmaceutical Drug Delivery Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Route Of Administration, Application, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Route Of Administration:

• Oral drug delivery system
• Nasal drug delivery system
• Ocular drug delivery systems
• Topical drug delivery system
• Other drug delivery system

By Application:

• Cancer
• Diabetes
• Cardiovascular Diseases
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Pharmaceutical Drug Delivery Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Pharmaceutical Drug Delivery Market, by Route Of Administration, 2019-2029 (USD Billion)
  • 1.2.3. Pharmaceutical Drug Delivery Market, by Application, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Drug Delivery Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Drug Delivery Market Dynamics

• 3.1. Pharmaceutical Drug Delivery Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. High incidences of chronic diseases among the population
    • 3.1.1.2. Growing investments in pharmaceutical R&D
  • 3.1.2. Market Challenges
    • 3.1.2.1. Increasing number of drug recalls and drug failures
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing trend of self-administration and home care
    • 3.1.3.2. Increasing technological advancements and new product launches

Chapter 4. Global Pharmaceutical Drug Delivery Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Drug Delivery Market, by Route Of Administration

• 6.1. Market Snapshot
• 6.2. Global Pharmaceutical Drug Delivery Market by Route Of Administration, Performance - Potential Analysis
• 6.3. Global Pharmaceutical Drug Delivery Market Estimates & Forecasts by Route Of Administration 2019-2029 (USD Billion)
• 6.4. Pharmaceutical Drug Delivery Market, Sub Segment Analysis
  • 6.4.1. Oral drug delivery system
  • 6.4.2. Nasal drug delivery system
  • 6.4.3. Ocular drug delivery systems
  • 6.4.4. Topical drug delivery system
  • 6.4.5. Other drug delivery system

Chapter 7. Global Pharmaceutical Drug Delivery Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Pharmaceutical Drug Delivery Market by Application, Performance - Potential Analysis
• 7.3. Global Pharmaceutical Drug Delivery Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Pharmaceutical Drug Delivery Market, Sub Segment Analysis
  • 7.4.1. Cancer
  • 7.4.2. Diabetes
  • 7.4.3. Cardiovascular Diseases
  • 7.4.4. Others

Chapter 8. Global Pharmaceutical Drug Delivery Market, Regional Analysis

• 8.1. Pharmaceutical Drug Delivery Market, Regional Market Snapshot
• 8.2. North America Pharmaceutical Drug Delivery Market
  • 8.2.1. U.S. Pharmaceutical Drug Delivery Market
    • 8.2.1.1. Route Of Administration breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Pharmaceutical Drug Delivery Market
• 8.3. Europe Pharmaceutical Drug Delivery Market Snapshot
  • 8.3.1. U.K. Pharmaceutical Drug Delivery Market
  • 8.3.2. Germany Pharmaceutical Drug Delivery Market
  • 8.3.3. France Pharmaceutical Drug Delivery Market
  • 8.3.4. Spain Pharmaceutical Drug Delivery Market
  • 8.3.5. Italy Pharmaceutical Drug Delivery Market
  • 8.3.6. Rest of Europe Pharmaceutical Drug Delivery Market
• 8.4. Asia-Pacific Pharmaceutical Drug Delivery Market Snapshot
  • 8.4.1. China Pharmaceutical Drug Delivery Market
  • 8.4.2. India Pharmaceutical Drug Delivery Market
  • 8.4.3. Japan Pharmaceutical Drug Delivery Market
  • 8.4.4. Australia Pharmaceutical Drug Delivery Market
  • 8.4.5. South Korea Pharmaceutical Drug Delivery Market
  • 8.4.6. Rest of Asia Pacific Pharmaceutical Drug Delivery Market
• 8.5. Latin America Pharmaceutical Drug Delivery Market Snapshot
  • 8.5.1. Brazil Pharmaceutical Drug Delivery Market
  • 8.5.2. Mexico Pharmaceutical Drug Delivery Market
  • 8.5.3. Rest of Latin America Pharmaceutical Drug Delivery Market
• 8.6. Rest of The World Pharmaceutical Drug Delivery Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bayer AG
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Becton, Dickinson and Company
  • 9.2.3. F. Hoffmann-La Roche AG
  • 9.2.4. GlaxoSmithKline Plc
  • 9.2.5. Johnson & Johnson Private Limited
  • 9.2.6. Merck & Co., Inc.
  • 9.2.7. Novartis AG
  • 9.2.8. 3M Company
  • 9.2.9. Pfizer Inc.
  • 9.2.10. Sanofi S.A.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption